Lupin seeks US FDA approval for generic Glumetza; Depomed may sue for patent violation
Depomed may take lagal route to protect the patent rights of it extended release antidiabetic pill Glumetza even as Lupin seeks regulatory approval to market a generic version of the the drug in US.
